On December 31, 2008, Regeneron Pharmaceuticals (REGN) had a market capitalization of $1.5B, based on 79.5M shares at a price of $18.26.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2008 | $18.26 | 9,741,000 | 79,498,000 | $1,451,530,132.60 |
November 2008 | $15.37 | 9,644,600 | 79,498,000 | $1,222,257,900.60 |
October 2008 | $19.19 | 14,289,100 | 79,498,000 | $1,525,844,863.00 |
September 2008 | $21.71 | 16,925,000 | 78,937,000 | $1,713,690,695.20 |
August 2008 | $21.60 | 12,932,400 | 78,937,000 | $1,705,054,987.40 |
July 2008 | $21.77 | 13,991,200 | 78,937,000 | $1,718,403,234.10 |
June 2008 | $14.36 | 17,958,600 | 78,689,000 | $1,130,005,515.60 |
May 2008 | $19.79 | 13,500,400 | 78,689,000 | $1,557,271,047.80 |
April 2008 | $19.51 | 9,983,300 | 78,689,000 | $1,535,364,030.20 |
March 2008 | $19.08 | 16,952,800 | 78,493,000 | $1,497,976,110.60 |
February 2008 | $19.66 | 11,527,800 | 78,493,000 | $1,543,250,873.00 |
January 2008 | $20.17 | 13,352,500 | 78,493,000 | $1,583,054,673.30 |
December 2007 | $24.02 | 12,706,300 | 78,493,000 | $1,885,150,682.40 |
November 2007 | $21.66 | 16,213,100 | 78,493,000 | $1,700,150,530.70 |
October 2007 | $21.88 | 15,354,300 | 78,493,000 | $1,717,324,799.10 |
September 2007 | $17.70 | 13,533,100 | 66,069,000 | $1,169,540,224.20 |
August 2007 | $19.35 | 24,471,500 | 66,069,000 | $1,278,613,536.30 |
July 2007 | $14.81 | 13,226,800 | 66,069,000 | $978,343,145.10 |
June 2007 | $17.82 | 28,420,800 | 65,950,000 | $1,175,308,140.00 |
May 2007 | $22.32 | 22,373,600 | 65,950,000 | $1,471,753,390.00 |
April 2007 | $27.05 | 16,149,100 | 65,950,000 | $1,783,947,500.00 |
March 2007 | $21.50 | 15,081,600 | 65,563,000 | $1,409,656,950.40 |
February 2007 | $19.73 | 12,044,600 | 65,563,000 | $1,293,597,327.80 |
January 2007 | $19.78 | 9,997,800 | 65,563,000 | $1,296,855,808.90 |
December 2006 | $19.96 | 9,467,700 | 65,563,000 | $1,308,591,585.90 |
